Oxytocin brukt som ristimulerende middel under födsel til friske gravide ved termin
Engelsk titel: Survey of the use oxytocin for labour augmentation in healthy pregnant at term
Läs online
Författare:
Kulseng AP
;
Jensen I
;
Huseby UB
Email: vindhuse@online.no
Språk: Nor
Antal referenser: 16
Dokumenttyp:
Artikel
UI-nummer: 03073051
Sammanfattning
Aim: The aim of the study was to
document the number of normal
pregnant women, at term, who
received oxytocin augmentation
in labour at the hospital in
Vestfold, Norway.
Material: There were 1174 births
in the period from June 1st. to
December 31st. 1999. The hospital
case notes from these births
were examined and 920 births
were included in the study. 254
cases were excluded.
Method: Retrospective observational
study. Case notes from the
included births were used to reply
the questionnaire.
Results: 48 % of the total study
population received oxytocin augmentation
in labour. Of those who
were primigravidae 69 % receiving
oxytocin, for multigravidae 34 %.
Most of the oxytocin was given on
a cervix dilatation at 8 -10 cm. The
most common way to administrate
oxytocin was intravenous infusion
(i.v) and intramuscular injection
(i.m). For 76 % it was not documentatet
that the doctor hade prescribt
it. The results indicate a higher
intstrumentel delivery rate and
an increase of bleeding by those
women who were augmentatet.
Conclusion: The study uncovered
non-systematic and varied administration
routins of the oxytocin.